SHANGHAI, Aug. 11, 2023 /PRNewswire/ -- Boqii Holding Limited ("Boqii (BQ)" or the "Company") today announced that it will change its ratio of its American Depositary Shares ("ADSs") to Class A ...
Biodexa Pharmaceuticals PLC, an acquisition-focused clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, today ...
Biodexa Pharmaceuticals PLC has announced a change in its American Depositary Receipts (ADR) ratio, effective July 31, 2025. The new ratio will be one ADR representing 100,000 ordinary shares, up from ...
SHANGHAI, Jan. 8, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback